These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20635944)

  • 1. Natural human immunoglobulins in cancer immunotherapy.
    Vollmers HP; Brändlein S
    Immunotherapy; 2009 Mar; 1(2):241-8. PubMed ID: 20635944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural antibodies and cancer.
    Vollmers HP; Brändlein S
    N Biotechnol; 2009 Jun; 25(5):294-8. PubMed ID: 19442595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural antibodies and cancer.
    Vollmers HP; Brändlein S
    J Autoimmun; 2007 Dec; 29(4):295-302. PubMed ID: 17826951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural monoclonal antibodies and cancer.
    Vollmers PH; Brändlein S
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):84-7. PubMed ID: 18537750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
    David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
    Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
    Schwartz-Albiez R; Laban S; Eichmüller S; Kirschfink M
    Autoimmun Rev; 2008 Jun; 7(6):491-5. PubMed ID: 18558368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring antibodies directed against carbohydrate tumor antigens.
    Schwartz-Albiez R
    Adv Exp Med Biol; 2012; 750():27-43. PubMed ID: 22903664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural IgM antibodies: the orphaned molecules in immune surveillance.
    Vollmers HP; Brändlein S
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):755-65. PubMed ID: 16820243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "early birds": natural IgM antibodies and immune surveillance.
    Vollmers HP; Brändlein S
    Histol Histopathol; 2005 Jul; 20(3):927-37. PubMed ID: 15944943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
    Brändlein S; Pohle T; Ruoff N; Wozniak E; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2003 Nov; 63(22):7995-8005. PubMed ID: 14633732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural IgM antibodies, the ignored weapons in tumour immunity.
    Brändlein S; Vollmers HP
    Histol Histopathol; 2004 Jul; 19(3):897-905. PubMed ID: 15168352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death by stress: natural IgM-induced apoptosis.
    Vollmers HP; Brandlein S
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):185-91. PubMed ID: 15834451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
    Livingston PO; Hood C; Krug LM; Warren N; Kris MG; Brezicka T; Ragupathi G
    Cancer Immunol Immunother; 2005 Oct; 54(10):1018-25. PubMed ID: 15926079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates.
    Gil J; Alvarez R; Viñuela JE; Ruiz de Morales JG; Bustos A; De la Concha EG; Subiza JL
    Cancer Res; 1990 Nov; 50(22):7301-6. PubMed ID: 2224860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies.
    Yu PB; Holzknecht ZE; Bruno D; Parker W; Platt JL
    J Immunol; 1996 Dec; 157(11):5163-8. PubMed ID: 8943428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
    David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
    Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a "thiol shield" protect tumors from natural IgM antibody, and, if so, how can it be suppressed?
    Jones PC
    Med Hypotheses; 2013 Apr; 80(4):425-30. PubMed ID: 23375413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble low-molecular-mass heat shock proteins and tumor-associated antigens in prevention and therapy of chemically-induced cancers.
    Zusman I; Kossoy G; Ben-Hur H
    In Vivo; 2001; 15(6):529-34. PubMed ID: 11887340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.